CNR Institutional Research Information System

ARBITRIO, MARIAMENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.119
NA - Nord America 1.306
EU - Europa 645
SA - Sud America 385
AF - Africa 38
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.496
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.260
SG - Singapore 873
CN - Cina 467
BR - Brasile 319
IT - Italia 312
HK - Hong Kong 226
VN - Vietnam 205
FR - Francia 120
KR - Corea 87
BD - Bangladesh 71
JP - Giappone 61
NL - Olanda 45
FI - Finlandia 44
IN - India 31
GB - Regno Unito 30
DE - Germania 24
AR - Argentina 19
CA - Canada 18
EC - Ecuador 16
MX - Messico 14
IL - Israele 12
ID - Indonesia 10
PK - Pakistan 10
AT - Austria 9
RU - Federazione Russa 9
SA - Arabia Saudita 9
TR - Turchia 9
ZA - Sudafrica 9
IQ - Iraq 7
CL - Cile 6
PH - Filippine 6
PL - Polonia 6
SE - Svezia 6
VE - Venezuela 6
EG - Egitto 5
ES - Italia 5
IE - Irlanda 5
PE - Perù 5
TN - Tunisia 5
UA - Ucraina 5
UY - Uruguay 5
UZ - Uzbekistan 5
CO - Colombia 4
KE - Kenya 4
MA - Marocco 4
PY - Paraguay 4
AZ - Azerbaigian 3
BH - Bahrain 3
CH - Svizzera 3
DZ - Algeria 3
HU - Ungheria 3
JO - Giordania 3
LT - Lituania 3
LV - Lettonia 3
NP - Nepal 3
OM - Oman 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BE - Belgio 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
HN - Honduras 2
KZ - Kazakistan 2
MY - Malesia 2
SN - Senegal 2
AL - Albania 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GA - Gabon 1
GN - Guinea 1
GR - Grecia 1
HR - Croazia 1
IM - Isola di Man 1
JM - Giamaica 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MG - Madagascar 1
MK - Macedonia 1
NI - Nicaragua 1
PR - Porto Rico 1
RE - Reunion 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
SV - El Salvador 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.496
Salva come PNG Salva come JPEG
Città #
Santa Clara 563
Singapore 495
Hong Kong 220
Hefei 213
San Jose 155
Ashburn 103
Lauterbourg 96
Seoul 85
Ho Chi Minh City 78
Beijing 69
Hanoi 48
Tokyo 43
Los Angeles 42
New York 37
Dallas 33
Council Bluffs 27
Lappeenranta 26
São Paulo 22
Helsinki 17
Rome 16
Milan 14
Buffalo 13
Benevento 12
Minamishinagawa 11
Hải Dương 10
Naples 10
Orem 10
Biên Hòa 9
Brooklyn 9
Rio de Janeiro 9
Falkenstein 8
Montreal 8
San Nicola Manfredi 8
Baghdad 7
Belo Horizonte 7
Amsterdam 6
Bari 6
Bengaluru 6
Bologna 6
Brasília 6
Palermo 6
Stockholm 6
Vienna 6
Atlanta 5
Boardman 5
Cagliari 5
Da Nang 5
Dhaka 5
Goiânia 5
Haiphong 5
Karachi 5
Lima 5
Mexico City 5
Phoenix 5
Quito 5
Tashkent 5
Curitiba 4
Dublin 4
Elk Grove Village 4
Frankfurt am Main 4
Guayaquil 4
Houston 4
Hyderabad 4
Jeddah 4
Miami 4
Montevideo 4
Nairobi 4
Pingdingshan 4
Rende 4
Santa Venerina 4
Thái Bình 4
Toritto 4
Tunis 4
Vallefiorita 4
Warsaw 4
Amman 3
Baku 3
Betim 3
Blumenau 3
Boston 3
Cairo 3
Campos dos Goytacazes 3
Carpi 3
Catanzaro 3
Chicago 3
Colombo 3
Contagem 3
Guarulhos 3
Hortolândia 3
Istanbul 3
Johannesburg 3
London 3
Manchester 3
Manila 3
Messina 3
Montalto Uffugo 3
Newark 3
Niterói 3
Nuremberg 3
Osaka 3
Totale 2.797
Salva come PNG Salva come JPEG
Nome #
The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis 115
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma 106
Mmrf-commpass data integration and analysis for identifying prognostic markers 88
The First-In-Class Anti-AXL×CD3? Pronectin(TM)-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas 84
Reprogrammed lipid metabolism in advanced resistant cancers: an upcoming therapeutic opportunity 83
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 81
DMET-analyzer: automatic analysis of Affymetrix DMET data 78
L-NAME prevents PGE2 accumulation but not enhancement of COX-2 expression in the brain of rats treated with lithium and tacrine 76
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 76
Development of a Pharmacogenetic Lab-on-Chip Assay Based on the In-Check Technology to Screen for Genetic Variations Associated to Adverse Drug Reactions to Common Chemotherapeutic Agents 71
PROTECTIVE EFFECTS OF BERGAMOT OIL EXTRACT ON MORPHINE TOLERANCE DESCRIBED BY HPLC/FLUORESCENCE ASSAY 70
Identifying prognostic markers for multiple myeloma through integration and analysis of MMRF-CoMMpass data 69
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 68
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 67
Inhibition of miR-21 as an innovative approach, to target Bone Disease, related to Th17 cells in Multiple Myeloma 66
APrognostic and Carboplatin Response Predictive Model in Ovarian CancerA Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics 66
A Novel Bispecific T-Cell Engager (CD1a x CD3") BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 66
Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates (vol 5, e326, 2016) 65
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience 64
Autophagy and neuroprotection in astrocytes exposed to 6-hydroxydopamine is negatively regulated by NQO2: relevance to Parkinson's disease. 63
DMET(TM) Genotyping: Tools for Biomarkers Discovery in the Era of Precision Medicine 63
Bioinformatic challenges for pharmacogenomic study: tools for genomic data analysis 61
Pharmacogenomics: Challenges and Future 59
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma 58
Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and LH/LH mice). 57
Polymorphic variants in NR1I3 and UGT2B7 predict taxane neurotoxicity and have prognostic relevance in breast cancer patients: a case-control study 57
Effetti biologici e comportamentali dopo esposizione prenatale ad etanolo nel ratto 56
Melatonin improves behavioural response on forced swimming test and decrease neuronal damage after paraquat treatment in two mice strains 56
Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity. 56
Microarray Data Analysis Protocol 56
Modeling UGT2B7 and NR1I3 genes through multilayer network to highlight hidden link with taxane neurotoxicity 55
ROLE OF MAP KINASES IN FETAL ALCHOOL SYNDROME 54
Scaling approaches for the prediction of human clearance of LNA-i-mir-221: A retrospective validation 54
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 52
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: a systematic review 52
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 50
Polymorphisms and Pharmacogenomics of NQO2: The Past and the Future 50
The State of The Art on Acetylcholinesterase Inhibitors in the Treatment of Alzheimer's Disease 50
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes 47
Ethical Perspectives on Pharmacogenomic Profiling 46
Precision Oncology: Present Status and Perspectives 43
ELECTROCORTICOGRAPHIC EFFECTS OF METHYLENEDIOXYMETHAMPHETAMINE (MDMA, ECSTASY) ARE POTENTIATED BY ACOUSTIC STIMULATION IN RATS 43
Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation Perspectives 43
Pharmacogenetics/Pharmacogenomics of Drug-Metabolizing Enzymes and Transporters 43
Prenatal ethanol exposure effects on map-kinases pathway in a genetic model of absence epilepsy: the WAG/Rij rat. 42
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma 42
The protective effect of olive oil phenols hydroxytyrosol and oleuropein on morphine tolerance. 42
Experimental treatment of multiple myeloma in the era of precision medicine 40
Preprocessing and Analysis of DMET Data for Pharmacogenomics 40
Allometric scaling approaches for predicting human pharmacokinetic of a locked nucleic acid oligonucleotide targeting cancer-associated miR-221 39
Pharmacogenomics Biomarker Discovery and Validation for Translation in Clinical Practice 39
Tools in Pharmacogenomics Biomarker Identification for Cancer Patients 38
Polymorphisms in ADME genes as potential predictor of multiple myeloma susceptibility 38
Integration of DNA Microarray with Clinical and Genomic Data 38
The best strategy for RAS wild-type metastatic colorectal cancer patients in first-line treatment: A classic and Bayesian meta-analysis 37
Development and validation of bioanalytical methods for LNA-i-miR-221 quantification in human plasma and urine by LC-MS/MS 36
Ethanol effects on map-kinases pathway in an experimental model of fethal alcohol sindrome (FAS). 36
Paraquat, MPTP, MPDP and MPP+ inibithion of acetylcholine and butyrylcholine esterases: a comparison to tacrine. 36
Esposizione al forced swimming test (FST) di Porsolt di topi trattati con il neurolettico atipico quetiapina fumarato. 35
miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy 33
Genetic variants associated with gastrointestinal symptoms in Fabry disease 33
Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma 33
miR-22 Modulates Lenalidomide Activity by Counteracting MYC Addiction in Multiple Myeloma 33
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats 33
OSAnalyzer: A Bioinformatics Tool for the Analysis of Gene Polymorphisms Enriched with Clinical Outcomes. 32
Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts 32
Error-prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment 32
Role of dopaminergic mechanism in the regulation of immune system. 31
Systemic administration of idebenone-cyclodextrin complex protects against paraquat-induced neuronal death in the hippocampus of rat 31
In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor. 31
Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: a DMET microarray profiling study 31
Electrocorticographic effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are potentiated by acoustic stimulation in rats 31
Effetti del neurolettico atipico quetiapina fumarato in topi KO iNOS dopo esposizione al forced swimming test (FST) di Porsolt. 31
Effetti comportamentali della sindrome alcolica fetale in due ceppi di ratto. 30
Behavioural despair in topi Kn NOSi dopo esposizione al Forced Swimming test (FST) di Porsolt 29
A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling. 29
Evidence that CRH microinfused into the Locus Coeruleus impairs immune response in rats 29
CISPLATINUM SENSITIVITY OF BRCA1-MUTATED HCC1937 BREAST CANCER CELLS IS LINKED TO IMPAIRMENT OF NOTCH SIGNALING AND IS INCREASED BY GAMMA-SECRETASE INHIBITORS 29
Inhibition of NK activity by CRH microinfused into the Locus Coeruleus in rats 28
Modulazione della produzione di citochine in topi vecchi. 28
Chronic maternal ethanol administration affects the developmentt of pentylenetetrazole kindling 28
Mouse models of multiple myeloma: Technologic platforms and perspectives 27
Modulazione della risposta comportamentale dopo trattamento con neurolettici atipici in topi ICR e KO NOSi. 27
Evidence that CRH microinfused into the locus coeruleus decreases cell-mediated immune response in rats. 26
Effetto di citochine sulla produzione di IL-2, IL-4 e IFN-? nella senescenza 26
Dopamine D1 receptors in amigdala enhance immune mechanism in rats. 26
Crhonic administration of paraquat produces immunosuppression of T lymphocytes and astrocytosis in rats 26
Chronic maternal ethanol administration in rat: morphological and histochemical findings in peripheral nerve 26
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy 26
Effects of neuroleptics treatment with quetiapine fumarate on immobility time of mice in the Porsolt forced swimming test 26
Cisplatinum Sensitivity of BRCA1-Mutated HCC1937 Breast Cancer Cells Is Linked to Impairment of Notch Signaling and Is Increased by ?-Secretase Inhibitors 25
EFFECTS OF ATYPICAL NEUROLEPTIC QUETIAPINE FUMARATE TREATMENT IN KO iNOS MICE AFTER EXPOSITION TO THE PORSOLT FORCED SWIMMING TEST 25
Evidence for an involvement of dopamine D1 receptors in the limbic system in the control of immune 25
Regulation of cytokine production in aging mice. 25
Melatonin improve behavioural response on forced swimming test (FST) after paraquat treatment in two mice strains. 25
Identification of polymorphic variants correlated to taxanes neurotoxicity in breast cancer patients by Dmet microarray platform. 25
miR-22 suppresses DNA ligase III addiction in multiple myeloma 24
A reappraisal of the role of the various opioid receptor subtypes in cell-mediated immunity 24
Modulazione della risposta immunitaria nel ratto da parte di recettori dopaminergici D1 nel complesso amigdaloideo. 23
In vivo anti-myeloma activity and modulation of gene expression profile induced by Valproic Acid, a histone deacetylase inhibitor 23
Totale 4.518
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.211
article - articoli 9.577
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.049
Totale 25.837
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20246 0 0 0 0 0 0 0 0 4 0 0 2
2024/20252.094 21 6 127 57 534 74 125 229 100 62 394 365
2025/20262.696 113 259 235 424 419 110 418 135 154 139 183 107
2026/20271 1 0 0 0 0 0 0 0 0 0 0 0
Totale 4.797